In November 2019, the US Advisory Committee on Immunization Practices (ACIP) updated its recommendations for pneumococcal vaccination among adults aged 65 years or older. The ACIP still recommends the PPSV23 vaccine for all adults aged 65 years or older but now advises clinicians use shared decision-making when recommending the PCV13 vaccination. Do you agree with this change?